Results 81 to 90 of about 64,835 (235)

Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study

Libyan Journal of Medicine, 2020
Introduction: Clostridioides difficile (C. difficile) infection (CDI) is one of the most common healthcare-associated (HA) infections in contemporary medicine.
Vesna Šuljagić, Bojana Milenković, Aneta Perić, Dragutin Jovanović, Vesna Begović-Kuprešanin, Srđan Starčević, Aleksandar Tomić, Sandra Vezmar Kovačević, Viktorija Dragojević-Simić   +8 more
doaj   +1 more source

From Barns to Bushes: Exploring the ECOFF-Based Non-Wild-Type Status of Campylobacter spp. in Pets, Livestock, Synanthropic Birds and Wild Animals in Northwestern Italy. [PDF]

Zoonoses Public Health
ABSTRACT Introduction Antimicrobial resistance (AMR) poses a significant threat to both humans and animals. Zoonotic bacteria, such as Campylobacter, contribute to human infections and the spread of AMR, particularly through livestock, pets and wildlife. We investigated the prevalence, distribution and EUCAST ECOFF‐based wild‐type (WT) vs.
Garcia-Vozmediano A, Moroni B, Marra C, Pitti M, Garofolo G, Marotta F, Di Romualdo R, Zoppi S, Ru G.   +8 more
europepmc   +2 more sources

The Need for a Revision of Fluoroquinolone Breakpoints for Interpretation of Antimicrobial Susceptibility Testing of Feline Bacterial Isolates

Journal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT The fluoroquinolone antimicrobial agents, enrofloxacin and marbofloxacin, were approved in the United States for cats in 1990 and 2001, respectively. In 2023, revised breakpoints for testing isolates from dogs were published. These canine breakpoints are discordant with the current feline breakpoints.
Mark G. Papich, Lacie A. Gunnett, Marilyn N. Martinez   +2 more
wiley   +1 more source

Fluoroquinolones in ambulatory surgical practice: whom, when, how?

Амбулаторная хирургия, 2016
The articLe discusses the indications and conditions for the use of fLuoroquinoLones (ciprofloxacin, LevofLoxacin, moxifLoxacin) in surgicaL infections of the skin and soft tissues in ambuLatory patients.
A. V. Golub, V. G. Pleshkov, V. V. Privol'nev   +2 more
doaj  

Duodenal ulcer promoting gene 1 (dupA1) is associated with A2147G clarithromycin-resistance mutation but not interleukin-8 secretion from gastric mucosa in Iraqi patients

New Microbes and New Infections, 2015
Helicobacter pylori causes peptic ulceration and gastric adenocarcinoma. The aims were to study the influence of dupA1 positivity upon interleukin-8 (IL-8) secretion from gastric mucosa and determine the prevalence of mutations responsible for ...
N.R. Hussein, I. Tunjel, H.S. Majed, S.T. Yousif, S.I. Aswad, M.S. Assafi   +5 more
doaj   +1 more source

Antibiotic‐mediated immune modulation in periodontitis

Periodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez, R. M. Arce, Camila Pinheiro Furquim, Cristiane Gonçalves, Alpdogan Kantarci, Magda Feres, Nidia C. Castro dos Santos   +6 more
wiley   +1 more source

Fluoroquinolone use restrictions in patients with uncomplicated infections and safety issues [PDF]

Клиническая микробиология и антимикробная химиотерапия, 2017
n May 2016, US FDA advised to restrict fluoroquinolones use in patients with acute sinusitis, acute exacerbations of chronic bronchitis, and uncomplicated urinary tract infections.
Ushkalova E.A., Zyryanov S.K.
doaj  

Antimicrobial Drug Prescribing for Pneumonia in Ambulatory Care

Emerging Infectious Diseases, 2005
To determine patterns and predictors of antimicrobial drug use for outpatients with community-acquired pneumonia, we examined office visit and pharmacy claims data of 4 large third-party payer organizations from 2000 to 2002.
Conan MacDougall, B. Joseph Guglielmo, Judy Maselli, Ralph Gonzales   +3 more
doaj   +1 more source

Role of BK Virus CTLs in the Treatment of BK Virus–Associated Nephropathy in Kidney‐Transplant and Hematopoietic Cell Transplant Recipients

Transplant Infectious Disease, EarlyView.
Third‐party, BK virus‐specific cytotoxic T lymphocytes (CTLs) were safe and effective in reducing viremia in kidney and stem cell transplant recipients with BK virus nephropathy. However, they did not improve kidney function. Earlier administration may be more beneficial before nephropathy and irreversible damage occur.
Amanda Olson, Ye Ethan Li, Rafet Basar, Pinaki Banerjee, Indresh Kaur, Glorette Abueg, Melihate Sylejmani, Nadima Uprety, Rejeena Shrestha, Francia Reyes Silva, Valda Page, Richard E. Champlin, Dimitrios P. Kontoyiannis, Roy F. Chemaly, Elizabeth J. Shpall, Linda Moore, Osama A. Gaber, Katayoun Rezvani, Ala Abudayyeh   +18 more
wiley   +1 more source

Adverse Effects of Fluoroquinolones: A Retrospective Cohort Study in a South Indian Tertiary Healthcare Facility

Antibiotics, 2019
The Food and Drug Administration (FDA) safety review revealed that the use of fluoroquinolones (FQs) is linked with disabling and potentially permanent serious adverse effects.
Benitta Mathews, Ashley Ann Thalody, Sonal Sekhar Miraj, Vijayanarayana Kunhikatta, Mahadev Rao, Kavitha Saravu   +5 more
doaj   +1 more source